Biosimilar Development

Solutions

  • Off the shelf fully validated assays 

  • Proprietary fingerprinting technology (Intelli.b TM) for biosimilar antibody characterization

  • Potency assays

  • Antibody functionality testing

  • Immunogenicity profiling and prediction

  • Regulatory ready biosimilar package

  • Integrated Summary of Immunogenicity (ISI) document by molecule

Accelerate your Biosimilar Development

The rise of biosimilars has provided challenges and opportunities in equal measure for biosimilar manufacturers. Somru BioScience has developed a portfolio of reagents, validated assays, and solutions that will enable companies to capitalize on the biosimilar opportunity.

Immunogenicity Profiling and Prediction

The potential for biosimilars to elicit an immunogenic response has become a hot-button issue among regulators, physicians, and patients. The key to de-risking any biosimilar program is to detect potential immunogenicity early in the development. It is critical for biosimilar developers to anticipate and avoid any issues with immunogenicity. Somru’s comprehensive immunogenicity profiling and prediction solutions can help you establish an immunogenicity profile to assess similarity early in the biosimilar development process to assess.

Regulatory-Ready Package by Molecule

We have consultants with decades of experience interacting with regulatory authorities from global jurisdictions  in biologics and biosimilar development. We have molecule specific regulatory documents such as non-clinical protocol, integrated summary of immunogenicity (ISI), IND submission package, and clinical protocols.

 

The road to biosimilarity is paved with successful immunogenicity prediction and confirmation.

Learn.
Engage.
Connect.

Learn | Engage | Connect

Read news, updates, and transforming technologies of drug development

Resources

Learn. Engage. Connect. Explore our scientific resources, articles and publications..

Read More ...

Ready to get started?

Consult with a Scientist today!